| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 5.29B | 5.33B | 5.69B | 5.17B | 3.67B | 2.17B |
| Gross Profit | 1.97B | 2.06B | 2.17B | 1.78B | 1.30B | 757.73M |
| EBITDA | 1.46B | 1.52B | 1.65B | 1.13B | 767.24M | 580.62M |
| Net Income | 1.04B | 1.08B | 1.20B | 883.16M | 551.74M | 425.88M |
Balance Sheet | ||||||
| Total Assets | 0.00 | 8.15B | 5.48B | 4.22B | 3.39B | 2.67B |
| Cash, Cash Equivalents and Short-Term Investments | 416.97M | 330.01M | 735.06M | 611.90M | 308.35M | 279.33M |
| Total Debt | 0.00 | 2.17M | 51.90M | 72.80M | 19.08M | 34.76M |
| Total Liabilities | -7.39B | 757.59M | 945.90M | 659.02M | 700.96M | 509.90M |
| Stockholders Equity | 7.39B | 7.31B | 4.47B | 3.49B | 2.62B | 2.09B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -73.46M | 494.76M | 887.62M | -91.37M | -149.48M |
| Operating Cash Flow | 0.00 | 693.34M | 973.81M | 1.08B | 133.75M | 92.59M |
| Investing Cash Flow | 0.00 | -2.73B | -468.50M | -1.03B | -7.44M | -65.32M |
| Financing Cash Flow | 0.00 | 1.76B | -239.11M | -64.39M | -56.59M | -44.42M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | ₹34.79B | 17.24 | ― | ― | 10.26% | 46.49% | |
75 Outperform | ₹27.03B | 26.88 | ― | 0.65% | -10.12% | -22.38% | |
64 Neutral | ₹29.96B | 34.93 | ― | 0.39% | 19.75% | 13.42% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
60 Neutral | ₹27.14B | 0.55 | ― | ― | -22.04% | -58.81% | |
45 Neutral | ₹13.40B | 33.05 | ― | ― | ― | ― | |
41 Neutral | ₹23.03B | -13.43 | ― | 0.43% | -11.11% | -340.74% |
Fineotex Chemical Limited has released the transcript of its earnings conference call covering the third quarter and nine-month financial performance for FY2025-26, held with investors and analysts on 16 February 2026. The disclosure, made under SEBI listing regulations and posted on the company’s website, underscores Fineotex’s ongoing engagement with the capital markets and its commitment to transparent communication of financial results to shareholders and market participants.
Fineotex Chemical Limited has submitted to the stock exchanges a compliance certificate from its registrar and share transfer agent, Bigshare Services Pvt. Ltd., confirming adherence to Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended December 31, 2025. The certificate states that all securities received for dematerialisation during the quarter were duly verified, either accepted or rejected, appropriately mutilated and cancelled where required, and that the depositories were recorded as the registered owners within the prescribed 15-day timeline, underscoring the company’s ongoing compliance with regulatory requirements in handling its listed securities.
Fineotex Chemical Limited announced a strategic acquisition of CrudeChem Technologies, a leading U.S. specialty oilfield chemicals group. This move is expected to enhance Fineotex’s market positioning in the oilfield chemicals sector, potentially expanding its global footprint and offering new growth opportunities for stakeholders.
Fineotex Chemical Limited announced the availability of an audio recording from an investor and analyst call discussing its recent acquisition of a leading U.S. specialty oilfield chemicals group. This strategic move is expected to enhance Fineotex’s market position in the specialty chemicals sector, particularly in the oilfield segment, potentially offering new growth opportunities and strengthening its international presence.
Fineotex Chemical Limited has successfully exercised warrants on a preferential basis, with significant participation from its promoter group, indicating strong confidence in the company’s growth prospects. The funds raised will be used for working capital and potential acquisitions, bolstering Fineotex’s expansion plans and reinforcing its market position both domestically and internationally.